Definition (সংজ্ঞা)
Depressive neurosis হলো একটি chronic, mild-to-moderate depression, যা দীর্ঘ সময় ধরে থাকে, কিন্তু কোন major depressive episode-এর তীব্রতা নেই। রোগী সাধারণত persistent sadness, irritability, low self-esteem সহ থাকে এবং দৈনন্দিন কাজকর্মে কিছুটা প্রভাব পড়ে।
আরও পরিচিত নামে: Dysthymia (DSM-5 অনুযায়ী Persistent Depressive Disorder)
Etiology / Causes (কারণ)
- Biological factors (জৈবিক কারণ):
- Serotonin, norepinephrine, dopamine-এর অসমতা
- Genetic predisposition (পরিবারে depression থাকলে ঝুঁকি বেশি)
- Psychological factors (মনস্তাত্ত্বিক কারণ):
- Chronic stress, childhood trauma
- Personality traits: low self-esteem, perfectionism
- Social / Environmental factors (সামাজিক/পরিবেশগত কারণ):
- Occupational stress
- Family conflicts, social isolation
- Financial difficulties
Clinical Features / Symptoms (লক্ষণ)
- Persistent sadness / melancholy
- Anxiety, tension
- Low self-esteem, guilt feelings
- Fatigue, lethargy
- Sleep disturbance (insomnia or hypersomnia)
- Poor concentration
- Loss of interest in daily activities (anhedonia)
- Somatic complaints: headache, backache, digestive issues
- Suicidal ideation (rare, mild compared to major depression)
Clinical Diagnosis & Investigations (ক্লিনিকাল ডায়াগনোসিস ও পরীক্ষা)
- Clinical Diagnosis:
- History & mental status examination
- DSM-5 criteria for Persistent Depressive Disorder:
- Depressed mood ≥ 2 years (adult)
- Two or more of: poor appetite/overeating, sleep disturbance, low energy, low self-esteem, poor concentration, hopelessness
- No major depressive episode lasting > 2 months
- Investigations (Rule out other causes):
- CBC (anemia, infection check)
- Thyroid function test (hypothyroidism mimic)
- Blood glucose / metabolic panel
- Vitamin B12 / Folate if indicated
- ECG if cardiovascular risk
Note: Mostly diagnosis is clinical, investigations are for exclusion of secondary causes.
Treatment / Management (চিকিৎসা ও ব্যবস্থাপনা):-
A. Pharmacological treatment (ড্রাগ থেরাপি)
- লক্ষ্য: Mood stabilization, energy increase, anxiety কমানো, function recovery
1. Selective Serotonin Reuptake Inhibitors (SSRIs)
- Fluoxetine
- Capsule 1.Prolert 20 mg AS A Fluoxetine Hydrochloride AS A Phenothiazine related drugs..
- Dose: 20–40 mg/day orally
- Duration: 6–12 months minimum
- Purpose: Depression & anxiety কমাতে, mood uplift করতে
- Side effects: Nausea, insomnia, headache, sexual dysfunction
- Interactions: MAO inhibitors (serotonin syndrome), NSAIDs (bleeding risk)
- Sertraline
- Tablet 2.Repose 50 Mg AS A Sertraline Hydrochloride AS A SSRIs & related anti-depressant drugs.
- Dose: 50–100 mg/day
- Purpose: Anxiety + depression
- Side effects: Diarrhea, dry mouth, insomnia
- Interactions: Warfarin (bleeding), CNS depressants
2. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
- Venlafaxine
- Tablet 3.Venlax 75 mg AS A Venlafaxine Hydrochloride AS A (SNRI).
- Dose: 75–150 mg/day
- Purpose: Resistant depressive symptoms, anxiety control
- Side effects: Hypertension, nausea, sweating
- Interactions: MAO inhibitors, triptans
3. Tricyclic Antidepressants (TCAs)
- Amitriptyline
- Tablet 4.Amilin 10 mg AS A Amitriptyline Hydrochloride Tricyclic Anti-depressant.
-
- Dose: 25–75 mg/day (start low, titrate)
- Purpose: Chronic depression, sleep disturbance
- Side effects: Anticholinergic (dry mouth, constipation), sedation, cardiac arrhythmia
- Interactions: MAO inhibitors, alcohol, CNS depressants
4. Adjunct / Anxiolytics (প্রয়োজনে)
- Buspirone (anxiety relief)
- Tablet 5.Anfree (0.5mg+ 10mg ) AS A (Flupentixol+Melitracen) AS A Combined anxiolytics & anti-depressant drugs.
- Dose: 15–30 mg/day
- Side effects: Dizziness, headache
- Interactions: MAO inhibitors
Important: Antidepressants কার্যকর হতে 2–6 সপ্তাহ সময় লাগে।
B. Non-Pharmacological Treatment
- Psychotherapy
- Cognitive Behavioral Therapy (CBT)
- Interpersonal Therapy (IPT)
- Lifestyle modification
- Regular exercise, sleep hygiene
- Balanced diet, social support
- Stress management
- Electroconvulsive Therapy (ECT)
- Rarely used only in resistant cases
Prevention (প্রতিরোধ)
- Stress management & mindfulness
- Regular physical activity
- Adequate sleep & nutrition
- Early recognition of mood changes
- Family/social support
- Avoid substance abuse (alcohol, sedatives)
Overview / Summary
Depressive neurosis (Persistent Depressive Disorder) হলো chronic mild-to-moderate depression। কারণগুলো মূলত biological, psychological, social। রোগীদের দীর্ঘমেয়াদী বিষণ্নতা, low self-esteem, anxiety, fatigue দেখা দেয়। Clinical diagnosis DSM-5 অনুযায়ী। Investigations মূলত secondary causes rule out-এর জন্য।
Management pharmacological (SSRIs, SNRIs, TCAs) এবং non-pharmacological (CBT, lifestyle) উভয়ই প্রয়োজন। Prevention মূলত stress reduction এবং early intervention।
Actionable Plan / Steps
- Detailed history + mental status exam
- Rule out secondary causes via labs
- Start SSRIs (Fluoxetine/Sertraline) 2–6 সপ্তাহ trial
- Monitor side effects & response
- Add psychotherapy (CBT/IPT)
- Educate patient on lifestyle & social support
- Long-term follow-up 6–12 months
Reference List
- Textbooks:
- Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, 10th ed., Chapter 10
- Harrison’s Principles of Internal Medicine, 20th ed., Chapter 344
- Guidelines:
- APA Practice Guideline for the Treatment of Patients with Major Depressive Disorder, 2020
- NICE Guideline: Depression in Adults: Treatment and Management, 2022
- Peer-reviewed journals:
- Cuijpers P, et al. “The efficacy of psychotherapy and pharmacotherapy in depressive disorders.” Lancet Psychiatry. 2019;6:289–300. doi:10.1016/S2215-0366(19)30002-9
- Cipriani A, et al. “Comparative efficacy and acceptability of antidepressants in the acute treatment of adults with major depressive disorder.” Lancet. 2018;391:1357–1366. doi:10.1016/S0140-6736(17)32802-7
| Drug Class | Generic Name | Dose | Duration | Purpose / Why Used | Common Side Effects | Drug Interactions |
| SSRI | Fluoxetine | 20–40 mg/day | 6–12 months | Chronic depression, anxiety, mood uplift | Nausea, insomnia, headache, sexual dysfunction | MAO inhibitors (serotonin syndrome), NSAIDs (bleeding risk) |
| SSRI | Sertraline | 50–100 mg/day | 6–12 months | Depression + anxiety control | Diarrhea, dry mouth, insomnia | Warfarin (bleeding), CNS depressants |
| SNRI | Venlafaxine | 75–150 mg/day | 6–12 months | Resistant depression, anxiety | Hypertension, nausea, sweating | MAO inhibitors, triptans |
| TCA | Amitriptyline | 25–75 mg/day | 6–12 months | Chronic depression, sleep disturbance | Sedation, dry mouth, constipation, arrhythmia | MAO inhibitors, alcohol, CNS depressants |
| Anxiolytic / Adjunct | Buspirone | 15–30 mg/day | As needed for anxiety | Anxiety relief in depressive neurosis | Dizziness, headache | MAO inhibitors |
Purpose / Use Explained (Why Used Specifically)
- SSRIs (Fluoxetine, Sertraline): First-line therapy; increase serotonin → improve mood & reduce anxiety.
- SNRIs (Venlafaxine): For resistant depression or when both serotonin & norepinephrine support needed.
- TCAs (Amitriptyline): Chronic depression with insomnia or pain symptoms; second-line due to side effects.
- Buspirone: Adjunct for anxiety without sedation or dependency risk.
Key Points
- Antidepressants take 2–6 weeks to show effect.
- Start low dose, titrate gradually.
- Monitor side effects: especially cardiovascular for TCAs, bleeding for SSRIs.
- Combine with psychotherapy & lifestyle modification for best outcomes.
Md.Rafiqul Islam Lipu,Date:-14-05-2026 Thursaday Time:-04-36-33 Pm